Compare Aitia vs Numerate
Customers evaluate the quality of Aitia's products using the following success metrics.
Overview
Aitia is 24 yrs old and is based in United States.
Aitia use causal AI and Digital Twins to discover the next generation of drugs. By leveraging the convergence of multi-omic patient data, high-performance computing, and causal learning and AI, Aitia is revealing the hidden biological mechanisms of disease to create Digital Twins of disease in oncology, neurodegenerative disorders, and immunology. Gemini Digital Twins are being used today to discover new therapies and accelerate R&D in multiple myeloma, prostate cancer, Alzheimer’s Disease, Parkinson’s Disease, and Huntington’s Disease, with several more in development. Aitia was founded in 2000 and is based in Somerville, Massachusetts.
Numerate is 17 yrs old and is based in United States.
Numerate is a privately held biotechnology company that applies machine-learning algorithms, at cloud scale, to overcome major challenges in small molecule drug discovery. Numerate's drug design platform combines advances in computer science and statistics with traditional medicinal chemistry approaches to address, in parallel, the factors that determine the success and failure of a drug candidate. Numerate is using this platform to develop a pipeline of drug programs in the cardiovascular, metabolic and neurodegenerative disease areas, focused on targets not typically addressed by computer-aided drug discovery. On September 25, 2020, Numerate was acquired by Valo Health. The terms of the transaction were not disclosed.
Demo Video
Leadership
Colin C Hill (Chief Executive Officer)
Nigel Duffy (Chief Technology Officer)
Investors
Paycheck Protection Program, Merck Global Health Innovation Fund
Valo Health, National Heart Lung and Blood Institute
Product
Why Aitia beats Numerate
Information not available because Numerate has not claimed their profile.
Work for Numerate? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Numerate?
Claim your profile now.
Benefits
Products
Customers
Known Partners
Why They Buy
News & Analysis
Aitia has been mentioned in our research 1 time.
Numerate has been mentioned in our research 1 time.
Research Articles
Jul 12, 2021
AI Acquisitions Are Red-Hot In These SectorsExpert Collections
Artificial Intelligence
10,944 items
Companies developing artificial intelligence solutions, including cross-industry applications, industry-specific products, and AI infrastructure solutions.
Digital Health 150
150 items
The most promising digital health startups transforming the healthcare industry
Artificial Intelligence
10,944 items
Companies developing artificial intelligence solutions, including cross-industry applications, industry-specific products, and AI infrastructure solutions.
Digital Health
10,563 items
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
Market
ESP Rankings position vendors based on their resources and execution.
Aitia is a Leader in Digital twins & biosimulation
The digital twins & biosimulation market utilizes computer models to simulate biological processes and predict the behavior of drugs and devices. This market offers a range of solutions that enable the creation of "digital twins" — virtual replicas of biological systems that can be used to test the safety and efficacy of new therapies. Overall, the digital twins & biosimulation market aims to augment drug discovery and development by leveraging advanced computational models and simulation techniques.